相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。In Vitro and In Vivo Activities of the Nitroimidazole TBA-354 against Mycobacterium tuberculosis
A. M. Upton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Pharmacokinetics and Pharmacodynamics of TMC207 and Its N-Desmethyl Metabolite in a Murine Model of Tuberculosis
Marie-Claude Rouan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis
Kathy Williams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Phase II Dose-Ranging Trial of the Early Bactericidal Activity of PA-824
Andreas H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis
Ian M. Rosenthal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis
C. Pierre-Audigier et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
Andreas H. Diacon et al.
LANCET (2012)
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
Maria Tarcela Gler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide
Robert S. Wallis et al.
PLOS ONE (2012)
Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis
Robert S. Wallis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Sterilizing Activity of Novel TMC207-and PA-824-Containing Regimens in a Murine Model of Tuberculosis
Rokeya Tasneen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Susceptibility of Clinical Mycobacterium tuberculosis Isolates to a Potentially Less Toxic Derivate of Linezolid, PNU-100480
J. W. C. Alffenaar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients
A. H. Diacon et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2011)
Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis
Nicolas Veziris et al.
PLOS ONE (2011)
Bactericidal Potencies of New Regimens Are Not Predictive of Their Sterilizing Potencies in a Murine Model of Tuberculosis
Koen Andries et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients
Andreas H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pharmacokinetics and Whole-Blood Bactericidal Activity against Mycobacterium tuberculosis of Single Doses of PNU-100480 in Healthy Volunteers
Robert S. Wallis et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Synthesis and Structure-Activity Relationships of Aza- and Diazabiphenyl Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
Iveta Kmentova et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis and Structure-Activity Studies of Biphenyl Analogues of the Tuberculosis Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
Brian D. Palmer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis
Murad Ibrahim et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Addition of PNU-100480 to First-Line Drugs Shortens the time Needed to Cure Murine Tuberculosis
Kathy N. Williams et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model
K. N. Williams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Andreas H. Diacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Enhanced bactericidal activity of rifampin and/or pyrazinamide when combined with PA-824 in a murine model of tuberculosis
Rokeya Tasneen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis
Eric Nuermberger et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates
Matsie Mphahlele et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Intermediates in the reduction of the antituberculosis drug PA-824, (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine, in aqueous solution
Robert F. Anderson et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model
Ian M. Rosenthal et al.
PLOS MEDICINE (2007)
Location of persisting mycobacteria in a guinea pig model of tuberculosis revealed by R207910
Anne J. Lenaerts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice
Makoto Matsumoto et al.
PLOS MEDICINE (2006)
Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration
Nacer Lounis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis
Eric Nuermberger et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis
S Tyagi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)